Deprenyl

N,alpha-dimethyl-N,2- propynyl phenethylamine, a MAO inhibitor which blocks the conversion of MPTP to MPP+ in animal models of Parkinson's disease, and may therefore have therapeutic potential.

As scientists who evolve with technology we treat innovation as a way of life, a life we dedicate to improvement and advancement of Safety, Health and Environment.
© Copyright 2026 Chemwatch
Chemwatch
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.